Recap: Immunogen Q3 Earnings

 

Immunogen IMGN reported its Q3 earnings results on Friday, October 29, 2021 at 06:30 AM.

Here's what investors need to know about the announcement.

Earnings

Immunogen reported in-line EPS of $-0.18 versus an estimate of $-0.18.

Revenue was up $8,979,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03, which was followed by a 0.71% drop in the share price the next day.

Here's a look at Immunogen's past performance:

 

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate -0.18 -0.19 -0.08 -0.18
EPS Actual -0.15 -0.17 0.16 -0.13
Revenue Estimate 18.92M 17.73M 40.83M 15.36M
Revenue Actual 16.95M 15.71M 85.80M 18.19M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!